April 22, 2011Alzheimer s & Dementia
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Authors
Discussion
Loading...
Member takes
Implication
Recommendations develop criteria for diagnosing mild cognitive impairment in Alzheimer's patients, highlighting the need for further validation.
Key Points
- This workgroup aims to establish diagnostic criteria for mild cognitive impairment associated with Alzheimer's disease.
- Developed core clinical criteria for healthcare providers without advanced imaging.
- Created research criteria for use in clinical trials incorporating biomarkers.
- Defined criteria with four levels of certainty based on biomarker findings.
- Initial criteria include both clinical evaluations and the use of biomarkers.
- Four levels of certainty enable clearer diagnostic guidelines depending on biomarker presence.
- Additional validation of biomarker criteria is necessary for community application.
Cite This Study
Albert et al. (2011) studied this question.